SCHEMBL217499

SCHEMBL217499

CC(C)CCOC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26131903 0.86 BLM (0.38)
SCHEMBL5836653 0.85 ALOX15 (0.47)
SCHEMBL11679430 0.84 RARB (0.40)
SCHEMBL2787526 0.83 BLM (0.50)
SCHEMBL8557263 0.82 RARB (0.39)
SCHEMBL8559662 0.82 RARB (0.39)
SCHEMBL28518589 0.82 RARB (0.39)
SCHEMBL28282898 0.82 RARB (0.39)
SCHEMBL29116299 0.81 CA1 (0.43)
SCHEMBL29059577 0.81 CA1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119504882-A Synthesis method of GalNAc derivative 北京炫景瑞医药科技有限公司 2025-02-25 CN claimed
CN-117164775-A Composition for preparing gel, preparation method of gel and synergistic improvement of CO 2 Method for recovering crude oil and geological storage rate 中国石油大学(北京) 2023-12-05 CN claimed
CN-122055369-A Bridged tricyclic carbamoyl pyridone compounds and uses thereof 吉利德科学公司 2026-05-15 CN disclosed
US-12599666-B2 Photolytic compounds and triplet-triplet annihilation mediated photolysis UNIVERSITY OF MASSACHUSETTS (US) 2026-04-14 US disclosed
US-20250122219-A1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. 2025-04-17 US disclosed
WO-2025080863-A1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2025-04-17 WO disclosed
EP-4486747-A1 ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. (US) 2025-01-08 EP disclosed
CN-118900839-A Antiviral compounds and methods of making and using the same 吉利德科学公司 2024-11-05 CN disclosed
WO-2024094637-A1 PROCESS FOR THE PREPARATION OF CYCLIC KETONES ARXADA AG (CH) 2024-05-10 WO disclosed
CN-117903036-A Synthesis and application of novel FXR (FXR) agonist 厦门市博瑞来医药科技有限公司 2024-04-19 CN disclosed
US-20230416275-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED 2023-12-28 US disclosed
US-4409140-A Substrates and method for determining enzymes SMITH ROBERT E (US) 1983-10-11 US disclosed
EP-0034586-B1 4-TRIFLUOROMETHYLCOUMARIN PEPTIDE DERIVATIVES AND THEIR USE IN PROTEINASE ASSAYS Smith, Robert Eugene (US) 1983-08-31 EP disclosed
EP-0018112-B1 SUBSTRATES AND METHOD FOR DETERMINING PROTEOLYTIC ENZYMES Smith, Robert Eugene (US) 1983-07-20 EP disclosed
US-4294923-A AMINO ACID DERIVATIVE OF 7-AMINO-4-TRIFLUOROMETHYL COUMARIN HYDROLYZED TO FREE CHROMOPHORE SMITH ROBERT E 1981-10-13 US disclosed
EP-0034586-A1 4-TRIFLUOROMETHYLCOUMARIN PEPTIDE DERIVATIVES AND THEIR USE IN PROTEINASE ASSAYS. SMITH ROBERT EUGENE (US) 1981-09-02 EP disclosed
EP-0034586-A4 4-TRIFLUOROMETHYLCOUMARIN PEPTIDE DERIVATIVES AND THEIR USE IN PROTEINASE ASSAYS. SMITH ROBERT EUGENE (US) 1981-05-15 EP disclosed
WO-1980002295-A1 4-TRIFLUOROMETHYLCOUMARIN PEPTIDE DERIVATIVES AND THEIR USE IN PROTEINASE ASSAYS SMITH R (US) 1980-10-30 WO disclosed
EP-0018112-A1 Substrates and method for determining proteolytic enzymes Smith, Robert Eugene (US) 1980-10-29 EP disclosed
US-3975538-A O-ALKOXYCARBONYL-2-ALKOXY-1-NAPHTHOHYDROXAMATES TAKEDA CHEMICAL INDUSTRIES, INC. (JA) 1976-08-17 US disclosed